On June 24th-25th, 2014 in Milan, Italy, the GAPP Project Assembly provided a detailed outline of the steps to be taken for the implementation of the GAPP studies, in terms of organization, timelines, protocols and budget feasibility. The resolutions of the meeting included specific, pressing topics such as the appointment of a GAPP Project Scientific Committee Chair and of a GAPP Scientific Coordinating Body.
Introducing the meeting, Prof. Ceci underlined the importance of the project in the context of European funding and paediatric research, while Dr. Aringhieri outlined that the GAPP Project is very challenging and Dompé will provide its contribution.
The GAPP non-clinical studies covered the topics of the first session, while two other sessions dealt exclusively with the implementation of the clinical study. A clear working framework for the project was provided by the appointment of the GAPP project bodies.
This first Project Assembly saw the appointment of the GAPP Project Scientific Committee as well as of the Scientific Coordination Body composed by the Chair Dr. Dick Tibboel, Dr. Laura Mangiarini, Dr. Mariagrazia Felisi, Dr. Rebecca Lundin, Dr. Tijtske Van der Zanden.
Dr. Donato Bonifazi, Managing Director of the Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) also informed the GA that the GAPP Ethics Board (EB), coordinated by CVBF through its Third Party Gianni Benzi Pharmacological Research Foundation (FGB), was appointed, with members Dr. Helen Sammons, Prof. Annagrazia Altavilla, Dr. Anouk Nijenhuis.
